Lim Wee Kiat
Age 31. Appointed to Board 15 March 2019, re-elected 9 October 2023. Appointed CEO of Thomson X subsidiary on 1 January 2022, redesignated as Executive Director. Appointed Executive Vice-Chairman 1 September 2022. Responsible for overall growth strategies and M&A activities in Southeast Asia. Started career with Kestrel Capital as Vice President (Investments). Involved in various investments, corporate finance transactions and business development with RSP Group. Co-founded and invested in healthcare technology, technology platforms and esports companies.
Board Appointments
| Company | Role | Status | Flags | Appointed | Resigned | Tenure |
|---|---|---|---|---|---|---|
| Thomson Medical Group LtdA50 | Executive Vice-Chairman | Current | Executive | 15 Mar 2019 | - | 7.1y |
Compensation History
| Company | FY | Role | Amount (SGD) | Type |
|---|---|---|---|---|
| Thomson Medical Group Ltd | 2024 | Executive Director | $625,000 | Executive |
Analysis presented is based on available data and disclosed methodology. Observations may not account for all relevant factors. This content is provided for educational and informational purposes only.